A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion
- 30 April 2000
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 36 (4), 215-223
- https://doi.org/10.1016/s0732-8893(99)00152-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Thirteen-Year Evolution of Azole Resistance in Yeast Isolates and Prevalence of Resistant Strains Carried by Cancer Patients at a Large Medical CenterAntimicrobial Agents and Chemotherapy, 1998
- Evaluation of the susceptibility of pathogenicCandida species to fluconazoleEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- Fluconazole treatment of Candidal infections caused by non-Albicans Candida speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transportersAntimicrobial Agents and Chemotherapy, 1995
- Resistance of Candida species to fluconazoleAntimicrobial Agents and Chemotherapy, 1995
- Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study GroupAntimicrobial Agents and Chemotherapy, 1995
- Correlation between in vitro susceptibility ofCandida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993